JUBLINGREA Stock Overview
Engages in the life science products and solutions in India, the United States, Europe, China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for JUBLINGREA from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Jubilant Ingrevia Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹765.00 |
| 52 Week High | ₹885.00 |
| 52 Week Low | ₹420.00 |
| Beta | 0.42 |
| 1 Month Change | 12.36% |
| 3 Month Change | 1.07% |
| 1 Year Change | 52.92% |
| 3 Year Change | 44.79% |
| 5 Year Change | n/a |
| Change since IPO | 184.70% |
Recent News & Updates
Is Jubilant Ingrevia (NSE:JUBLINGREA) Using Too Much Debt?
Dec 18
We Think Jubilant Ingrevia (NSE:JUBLINGREA) Is Taking Some Risk With Its Debt
Sep 11Recent updates
Is Jubilant Ingrevia (NSE:JUBLINGREA) Using Too Much Debt?
Dec 18We Think Jubilant Ingrevia (NSE:JUBLINGREA) Is Taking Some Risk With Its Debt
Sep 11Jubilant Ingrevia (NSE:JUBLINGREA) Is Reinvesting At Lower Rates Of Return
Aug 14Jubilant Ingrevia Limited Just Missed Earnings - But Analysts Have Updated Their Models
Jul 19Earnings Tell The Story For Jubilant Ingrevia Limited (NSE:JUBLINGREA) As Its Stock Soars 29%
Apr 13Jubilant Ingrevia Limited Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next
Feb 02A Look At The Fair Value Of Jubilant Ingrevia Limited (NSE:JUBLINGREA)
Feb 01Returns At Jubilant Ingrevia (NSE:JUBLINGREA) Are On The Way Up
Oct 19Market Cool On Jubilant Ingrevia Limited's (NSE:JUBLINGREA) Earnings
Jun 08Jubilant Ingrevia (NSE:JUBLINGREA) Is Due To Pay A Dividend Of ₹2.50
Feb 03Investors Should Be Encouraged By Jubilant Ingrevia's (NSE:JUBLINGREA) Returns On Capital
Dec 14Calculating The Fair Value Of Jubilant Ingrevia Limited (NSE:JUBLINGREA)
Oct 07Jubilant Ingrevia Limited Just Missed Revenue By 86%: Here's What Analysts Think Will Happen Next
May 22Shareholder Returns
| JUBLINGREA | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -8.2% | -3.8% | -4.2% |
| 1Y | 52.9% | 5.4% | 19.1% |
Return vs Industry: JUBLINGREA exceeded the Indian Chemicals industry which returned 5.4% over the past year.
Return vs Market: JUBLINGREA exceeded the Indian Market which returned 19.1% over the past year.
Price Volatility
| JUBLINGREA volatility | |
|---|---|
| JUBLINGREA Average Weekly Movement | 6.5% |
| Chemicals Industry Average Movement | 5.8% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: JUBLINGREA has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: JUBLINGREA's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 2,283 | Deepak Jain | jubilantingrevia.com |
Jubilant Ingrevia Limited engages in the life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions.
Jubilant Ingrevia Limited Fundamentals Summary
| JUBLINGREA fundamental statistics | |
|---|---|
| Market cap | ₹120.86b |
| Earnings (TTM) | ₹1.76b |
| Revenue (TTM) | ₹41.10b |
68.8x
P/E Ratio2.9x
P/S RatioIs JUBLINGREA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JUBLINGREA income statement (TTM) | |
|---|---|
| Revenue | ₹41.10b |
| Cost of Revenue | ₹20.89b |
| Gross Profit | ₹20.21b |
| Other Expenses | ₹18.46b |
| Earnings | ₹1.76b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 28, 2025
| Earnings per share (EPS) | 11.11 |
| Gross Margin | 49.18% |
| Net Profit Margin | 4.27% |
| Debt/Equity Ratio | 25.3% |
How did JUBLINGREA perform over the long term?
See historical performance and comparisonDividends
0.7%
Current Dividend Yield43%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 06:17 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jubilant Ingrevia Limited is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Satish Kumar | CGS International |
| Siddharth Gadekar | Equirus Securities Private Limited |
| Prateek Parekh | Nuvama Wealth Management Limited |